NEW!!! Many of our products can now be purchased online! Please browse the product pages for more information.
For custom quotations/inquiries, contact us through the online form or by emailing Thank you for your patience as we continue to update our website!

Advisory Board

Dennis Whitfield, Ph.D., Scientific Advisor, is a Senior Research Officer with the Eukaryotic Glycobiology Group at NRC where his group is developing synthetic methodologies for advancing NRC’s glycotherapeutics program. Focus is on Glycosylation (synthesis and mechanistic theory), heparin fragments synthesis and biophysical studies, soluble polymers (applied to synthesis of oligosaccharides) and chemoenzymatic synthesis. Dr. Whitfield has extensive publications as well as patents and applications on his scientific work and is inventor of the Sussex Research PEGylated Glycoside technology. Prior to joining NRC, Dr. Whitfield held research positions at the University of Toronto, the Hospital for Sick Children (Toronto) and the Ludwig Institute for Cancer Research (Toronto). Dr. Whitfield received a doctorate in chemistry from Victoria University in 1984.

In memoriam

Malcolm Perry, Ph.D., Scientific Advisor, was a renowned researcher in microbiology and immunochemistry with over 50 years of experience in the study of Bacterial Pathogenesis at the National Research Council of Canada. Dr. Perry’s research has focused on bacterial pathogens that affect human populations, from hospital-related and food or animal sources. Dr. Perry and his group have isolated and characterized hundreds of lipopolysaccharides and capsular polysaccharides enroute to identifying and developing solutions for eliminating particularly virulent forms of bacteria. Dr. Malcolm Perry passed away on June 25, 2012 at the age of 82.